Trident Capital is a leading venture capital and private equity firm committed to empowering entrepreneurs to build innovative and industry-leading businesses. Founded in 1993, Trident has more than $1.9 billion of capital under management across seven funds. The firm focuses on investments in software, Internet, and technology-enabled services. Within its sector focus, Trident invests across multiple stages (including early and late stage venture capital), as well as growth equity and buyouts. Trident has investment offices in Palo Alto, CA and Westport, CT. For more information, please visit www.tridentcap.com.
HLM Venture Partners
HLM Venture Partners is a leading venture capital firm, providing capital to emerging companies focused on health care services, health care information technology, and medical devices. HLM has over $400 million of venture capital under management and works with the leading growth companies that are improving the quality of health care while reducing overall costs. HLM supports entrepreneurs as they turn innovative ideas into market-leading businesses, offering guidance on financial structuring, resource allocation and deployment, strategic planning, strategic introductions, and recruitment. HLM has offices in Boston, MA, and San Francisco, CA. For more information, please visit www.hlmventurepartners.com.
Sandbox/BCBS Venture Fund
Sandbox Industries (www.sandboxindustries.com) is a Chicago-based firm that connects innovative companies into its corporate partners in Healthcare and Food & Agriculture. Founded in 2003, Sandbox has over $400 million of capital under management and exclusively manages the BlueCross BlueShield Venture Partners, L.P. (www.bcbsvp.com), which is a $305 million corporate venture fund licensed by the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield companies. The fund invests in promising emerging companies of strategic relevance to Blue Cross and Blue Shield companies.
By RaeAnn Grossman What are the new trends in Medicare Advantage risk adjustment and premium accuracy? Monthly reporting on your RAPS to EDS impact on RAF (monitoring your data compilation and completeness) Starting your in-patient medical record review as early as possible Conducting as many second level reviews as your budget allows; 2LR typically yields […]
By RaeAnn Grossman Pharma. The most interesting and accurate data for persistent and inferred conditions is pharmacy data. If you know your pharma data, you can create a member profile for retrospective, concurrent, and care targeting. Prescriptions are typically closely aligned with conditions, not always at a one-to-one ratio. Make certain you have the complete […]